Trade Pharming Group N.V. - PHAR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.003 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017952% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004271% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 10 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Netherlands | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.779 |
| Open | 0.773 |
| 1-Year Change | -24.07% |
| Day's Range | 0.744 - 0.773 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 0.779 | -0.013 | -1.64% | 0.792 | 0.797 | 0.769 |
| Mar 28, 2025 | 0.796 | 0.010 | 1.27% | 0.786 | 0.810 | 0.782 |
| Mar 27, 2025 | 0.811 | 0.002 | 0.25% | 0.809 | 0.828 | 0.800 |
| Mar 26, 2025 | 0.811 | -0.001 | -0.12% | 0.812 | 0.818 | 0.807 |
| Mar 25, 2025 | 0.810 | 0.014 | 1.76% | 0.796 | 0.827 | 0.786 |
| Mar 24, 2025 | 0.799 | -0.018 | -2.20% | 0.817 | 0.821 | 0.799 |
| Mar 21, 2025 | 0.797 | 0.013 | 1.66% | 0.784 | 0.803 | 0.770 |
| Mar 20, 2025 | 0.802 | -0.002 | -0.25% | 0.804 | 0.828 | 0.789 |
| Mar 19, 2025 | 0.797 | 0.004 | 0.50% | 0.793 | 0.801 | 0.784 |
| Mar 18, 2025 | 0.794 | -0.009 | -1.12% | 0.803 | 0.813 | 0.790 |
| Mar 17, 2025 | 0.804 | 0.019 | 2.42% | 0.785 | 0.821 | 0.773 |
| Mar 14, 2025 | 0.782 | -0.054 | -6.46% | 0.836 | 0.851 | 0.769 |
| Mar 13, 2025 | 0.825 | 0.094 | 12.86% | 0.731 | 0.832 | 0.729 |
| Mar 12, 2025 | 0.712 | -0.004 | -0.56% | 0.716 | 0.735 | 0.709 |
| Mar 11, 2025 | 0.713 | -0.018 | -2.46% | 0.731 | 0.736 | 0.709 |
| Mar 10, 2025 | 0.738 | -0.013 | -1.73% | 0.751 | 0.753 | 0.719 |
| Mar 7, 2025 | 0.752 | -0.013 | -1.70% | 0.765 | 0.778 | 0.747 |
| Mar 6, 2025 | 0.769 | -0.030 | -3.75% | 0.799 | 0.809 | 0.759 |
| Mar 5, 2025 | 0.807 | 0.002 | 0.25% | 0.805 | 0.849 | 0.799 |
| Mar 4, 2025 | 0.836 | -0.025 | -2.90% | 0.861 | 0.866 | 0.835 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Pharming Group Company profile
About Pharming Group N.V.
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Pharming Group N.V. revenues decreased 10% to EUR167.7M. Net income decreased 59% to EUR13.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Research and development increase of 76% to EUR59.3M (expense), General and administrative increase of 48% to EUR31.2M (expense).
Equity composition
4/2010, Nominal value changed from EUR 0.5. 07/2012, Nominal value changed from EUR0.04. 3/2013, 1-for-10 reverse stock split (Factor: 0.1 ). 3/2013, Nominal value changed from EUR0.1 to EUR0.01. 11/2016, Rights Issue, 1 new share for every 7 shares held @ 0.205EUR, (Factor: 1.00751).
| Industry: | Pharmaceuticals (NEC) |
Darwinweg 24
LEIDEN
ZUID-HOLLAND 2333 CR
NL
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com